ArticleJournal of cardiothoracic surgery2026
Bronchus and lung cancer-related mortality trends in the United States from 1999 to 2023.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBronchus and lung cancer are one of the most common and deadly types of cancer in the United States. This study analyzed the mortality trends related to bronchus and lung cancer among U.S. adults ≥ 25 years old from 1999 to 2023 from demographic and geographic perspectives.
methodsWe utilized the CDC WONDER database to investigate the trends in Bronchus and lung cancer-related mortality in the United States. Age-adjusted mortality rates per 100,000 people (AAMR), annual percentage change (APC), and average annual percentage change (AAPC) with 95% confidence intervals (CIs) were calculated, and the data were stratified by year, age groups, sex, race/ethnicity, census region, urban–rural, and states classification. The Joinpoint Regression Program was utilized to estimate mortality trends between 1999 and 2023.
resultsFrom 1999 to 2023, 3 778 040 bronchus and lung-cancer deaths were recorded. The AAMRs fell from 55.41 per 100 000 (95% CI: 55.14 to 55.69) in 1999 to 29.49 (95% CI: 29.33 to 29.65) in 2023, yielding an average AAPC of -2.63% (95% CI: -2.92 to -2.34; p < 0.001). Crude mortality rates decreased in every age group; The 25–34 age group maintained the lowest CMRs, and decreased modestly (AAPC: -2.515, 95% CI: -3.07 to -1.96). Males exhibited higher AAMRs than females, but their decline was steeper (male AAPC: -3.35%; 95% CI: -3.68 to -3.01 vs female -1.85%; 95% CI: -2.09 to -1.61; both p < 0.001). Non-Hispanic Black individuals had the highest AAMRs consistently but recorded the fastest decrease (AAPC -3.05%; 95% CI: -3.26 to -2.83; p < 0.001), while Hispanic or Latino individuals had the lowest (AAMR 2023: 20.21; 95% CI: 19.67 to 20.75). Geographically, the West had the lowest AAMR and the sharpest decline (AAPC: -3.21%; 95% CI: -3.57 to -2.84; p < 0.001). Metropolitan areas improved faster than non-metropolitan areas (AAPC: -2.83% vs -1.73%; both p < 0.001). By state, the largest 1999 to 2023 reductions were observed in the District of Columbia (-59%), Nevada (-57%), and California (-56%), whereas Kentucky remained the highest in 2023 (AAMR: 75.62; 95% CI: 74.28 to 76.96). A minor rebound in 2020–2023 (APC: -3.02%; 95% CI: -3.79 to -2.24; p = 0.004) coincided with the COVID-19 period.
conclusionIt is crucial to assess potential health disparities among different regions and population groups. There is an urgent need for further research and the implementation of targeted public health interventions, as well as improvements in resource allocation and health outcomes among populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.